Diagnosis and management of multiple sclerosis and other relapsing demyelinating disease in childhood
- PMID: 34230009
- DOI: 10.1136/archdischild-2021-321911
Diagnosis and management of multiple sclerosis and other relapsing demyelinating disease in childhood
Abstract
There are several important relapsing demyelinating syndromes (RDS) that may present in childhood, of which paediatric-onset multiple sclerosis is the most common. These are rare conditions, so recognising presentations and referring early to specialist services is important to enable prompt diagnosis and effective treatment. Understanding of RDS is rapidly evolving, with many new and effective treatments that aim to reduce relapses and disability accumulation. A holistic and child-focused approach to management is key to supporting patients and families, with thought given to early detection of cognitive and psychological issues to provide appropriate support.
Keywords: pathology; pharmacology; psychology; syndrome; therapeutics.
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: CH has received educational grants from Biogen and provided consultant advice for Novartis, VielaBio and Biogen. Dr Ming Lim receives research grants from Action Medical Research, the DES Society, GOSH Charity, National Institute for Health Research, MS Society and SPARKS Charity; receives research support grants from the London Clinical Research Network and Evelina Appeal; has received consultation fees from CSL Behring, Novartis and Octapharma; received travel grants from Merck Serono; and was awarded educational grants to organise meetings by Novartis, Biogen Idec, Merck Serono and Bayer.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources